Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?

1. Ferlay J, Shin HR, Bray F, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.10.1002/ijc.2551621351269Search in Google Scholar

2. Ferlay J, Soerjomataram I, Dikshit R, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-E386.10.1002/ijc.2921025220842Search in Google Scholar

3. Ajani JA, Bentrem DJ, Besh S, et al.: Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:531-46.10.6004/jnccn.2013.007023667204Search in Google Scholar

4. Okines A, Verheij M, Allum W, et al.: Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v50-4. doi: 10.1093/annonc/mdq164.:v50-v54.10.1093/annonc/mdq164.:v50-v54Open DOISearch in Google Scholar

5. Chang JS, Kim KH, Keum KC, et al.: Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration. J Surg Oncol. 2016;114:859-64.10.1002/jso.2440527511744Search in Google Scholar

6. Seyfried F, von Rahden BH, Miras AD, et al.: Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer 2015;15:73. doi: 10.1186/s12885-015-1081-8.:73-1081, 201510.1186/s12885-015-1081-8.:73-10812015Open DOISearch in Google Scholar

7. Yonemura Y, Endou Y, Sasaki T, et al.: Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol. 2010;36:1131-8.10.1016/j.ejso.2010.09.00620933363Search in Google Scholar

8. Roviello F, Caruso S, Neri A, et al.: Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol. 2013;39:1309-16.10.1016/j.ejso.2013.10.01024183797Search in Google Scholar

9. Yan TD, Black D, Sugarbaker PH, et al.: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702-13.10.1245/s10434-007-9487-417653801Open DOISearch in Google Scholar

10. Mi DH, Li Z, Yang KH, et al.: Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia 2013;29:156-67.10.3109/02656736.2013.76835923418917Search in Google Scholar

11. Sun J, Song Y, Wang Z, et al.: Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013;13:577. doi: 10.1186/1471-2407-13-577.:577-13.10.1186/1471-2407-13-577.:577-13Open DOISearch in Google Scholar

12. Yan TD, Edwards G, Alderman R, et al.: Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma-a prospective study of 70 consecutive cases. Ann Surg Oncol. 2007;14:515-25.10.1245/s10434-006-9187-5Open DOISearch in Google Scholar

13. Coccolini F, Cotte E, Glehen O, et al.: Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol. 2014;40:12-26.10.1016/j.ejso.2013.10.019Open DOISearch in Google Scholar

14. Van Der Speeten K, Stuart OA, Sugarbaker PH: Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am. 22012;21:577-97.10.1016/j.soc.2012.07.013Search in Google Scholar

15. Braam HJ, Schellens JH, Boot H, et al.: Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Crit Rev Oncol Hematol. 2015;95:282-96.10.1016/j.critrevonc.2015.04.004Search in Google Scholar

16. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359-74.10.1007/978-1-4613-1247-5_23Search in Google Scholar

17. Glehen O, Gilly FN, Arvieux C, et al.: Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370-7.10.1245/s10434-010-1039-7Open DOISearch in Google Scholar

18. Gill RS, Al-Adra DP, Nagendran J, et al.: Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011;104:692-8.10.1002/jso.22017Search in Google Scholar

19. Rau B, Löffler M, Rau HG, et al.: Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study (GASTRIPEC). J Clin Oncol. 2015;33, (abstr).10.1200/jco.2015.33.15_suppl.tps4132Search in Google Scholar

20. Al-Batran SE, Hofheinz RD, Pauligk C, et al.: Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol. 2016;17(12):1697-708.10.1016/S1470-2045(16)30531-9Search in Google Scholar

21. Costa WL, Jr., Coimbra FJ, Ribeiro HS, et al.: Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients. World J Surg Oncol. 2012;10:195. doi: 10.1186/1477-7819-10-195.:195-10, 2012Search in Google Scholar

22. Huang JY, Xu YY, Sun Z, et al.: Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:4379-85.10.7314/APJCP.2012.13.9.4379Search in Google Scholar

23. Yang XJ, Huang CQ, Suo T, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575-81.10.1245/s10434-011-1631-5308787521431408Search in Google Scholar